Glipizide and Repaglinide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glipizide (glipizide) and Repaglinide (repaglinide). Common drug interactions include nausea among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Glipizide and Repaglinide. It is created by eHealthMe based on reports of 81 people who take the same drugs from the FDA, and is updated regularly.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.

On Jul, 16, 2026

81 people who take Glipizide and Repaglinide together, and have interactions are studied.

Glipizide and Repaglinide drug interactions.

What are the common drug interactions of Glipizide and Repaglinide, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Weight decreased
Photopsia (presence of perceived flashes of light)
Abdominal distension
Abdominal pain upper
Activities of daily living impaired
Anaemia (lack of blood)
Anxiety

male:

Chronic kidney disease
Constipation
Coma (state of unconsciousness lasting more than six hours)
Hypertension (high blood pressure)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Transfusion reaction (a serious problem that occurs after a patient receives a transfusion of blood)
Cardiac failure
Depression
Anaemia postoperative
Azotaemia (excess of urea or other nitrogenous compounds in the blood)

What are the common drug interactions of Glipizide and Repaglinide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Diabetes mellitus inadequate control

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Memory impairment
Tremor (trembling or shaking movements in one or more parts of your body)
Activities of daily living impaired
Ageusia (loss of taste functions of the tongue)
Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
Blood glucose decreased
Blood glucose increased
Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
Burning sensation
Cardiomegaly (increased size of heart than normal)

60+:

Constipation
Chronic kidney disease
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Coma (state of unconsciousness lasting more than six hours)
Hypertension (high blood pressure)
Hypoaesthesia (reduced sense of touch or sensation)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Nausea (feeling of having an urge to vomit)
Transfusion reaction (a serious problem that occurs after a patient receives a transfusion of blood)
Cardiac failure

What are the existing conditions these people have? *

Type 2 Diabetes: 18 people, 22.22%
High Blood Pressure: 13 people, 16.05%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 13.58%
High Blood Cholesterol: 8 people, 9.88%
Cardiac Disorder: 7 people, 8.64%
Pain: 5 people, 6.17%

* Approximation only. Some reports may have incomplete information.

Do you take Glipizide and Repaglinide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously